New treatment options for overactive bladder and incontinence.
Newman
Diane Kaschak
DK
Penn Center for Continence and Pelvic Health Division of Urology, University of Pennsylvania Health System, 1st Floor, Rhodes Pavilion, 3400 Spruce Street, Philadelphia, PA 19104, USA. dnewman@seekwellness.com
D000368:Aged; D001559:Benzhydryl Compounds / Q000627:therapeutic use; D018680:Cholinergic Antagonists / Q000627:therapeutic use; D003408:Cresols / Q000627:therapeutic use; D015577:Geriatric Assessment; D005851:Geriatric Nursing / Q000379:methods; D006801:Humans; D008333:Mandelic Acids / Q000627:therapeutic use; D018727:Muscarinic Antagonists / Q000627:therapeutic use; D024802:Nurse's Role; D009730:Nursing Assessment / Q000379:methods; D009735:Nursing Homes; D010665:Phenylpropanolamine; D015995:Prevalence; D014039:Toilet Training; D000068737:Tolterodine Tartrate; D001745:Urinary Bladder Diseases / Q000453:epidemiology / Q000628:therapy*; D014549:Urinary Incontinence / Q000453:epidemiology / Q000628:therapy*
D001559:Benzhydryl Compounds; D018680:Cholinergic Antagonists; D003408:Cresols; D008333:Mandelic Acids; D018727:Muscarinic Antagonists; D010665:Phenylpropanolamine; D000068737:Tolterodine Tartrate; C005419:oxybutynin